Keyt Bruce 4
4 · IGM Biosciences, Inc. · Filed Dec 15, 2023
Insider Transaction Report
Form 4
Keyt Bruce
Chief Scientific Officer
Transactions
- Sale
Common Stock
2023-12-13$5.78/sh−7,574$43,764→ 129,551 total
Holdings
- 1,013(indirect: See footnote)
Common Stock
Footnotes (3)
- [F1]These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units.
- [F2]This transaction was executed in multiple trades at prices ranging from $5.58 to $6.00. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- [F3]The shares are held directly by the Reporting Person's spouse.